Medication adherence and cognitive performance in schizophrenia-spectrum and bipolar disorder: results from the PsyCourse Study

被引：8

作者：

Senner, Fanny ^{[1
,2
]}

Hiendl, Lena ^{[3
]}

Bengesser, Susanne ^{[3
]}

Adorjan, Kristina ^{[1
,2
]}

Anghelescu., Ion-George ^{[4
]}

Baune., Bernhardt T. ^{[5
,6
,8
]}

Budde, Monika. ^{[2
]}

Dannlowski, Udo ^{[7
]}

Dietrich, Detlef E. ^{[9
,10
]}

Falkai, Peter ^{[1
]}

Fallgatter, Andreas J. ^{[11
]}

Hasan, Alkomiet ^{[12
]}

Heilbronner, Maria ^{[2
]}

Jaeger, Markus ^{[13
]}

Juckel, Georg ^{[14
]}

Kalman, Janos L. ^{[1
,2
]}

Konrad, Carsten ^{[15
]}

Kohshour, Mojtaba Oraki ^{[2
,16
]}

Papiol, Sergi ^{[1
,2
]}

Reich-Erkelenz, Daniela ^{[2
]}

Reimer, Jens ^{[17
,18
]}

Schaupp, Sabrina K. ^{[2
]}

Schmauss, Max ^{[12
]}

Senner, Simon ^{[19
]}

Spitzer, Carsten ^{[20
]}

Vogl, Thomas ^{[2
]}

Zimmermann, Joerg ^{[21
]}

Heilbronner, Urs ^{[2
]}

Schulte, Eva C. ^{[1
,2
,22
,23
]}

Schulze, Thomas G. ^{[2
,24
]}

Reininghaus, Eva Z. ^{[3
]}

Kirchner, Sophie-Kathrin ^{[1
,12
]}

Dalkner, Nina ^{[3
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Psychiat & Psychotherapy, D-80336 Munich, Germany

[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Psychiat Phen & Genom, D-80336 Munich, Germany

[3] Med Univ Graz, Dept Psychiat & Psychotherapeut Med, Res Unit Neurobiol & Anthropometr Bipolar Affect, A-8036 Graz, Austria

[4] Mental Hlth Inst Berlin, Dept Psychiat & Psychotherapy, D-14050 Berlin, Germany

[5] Univ Munster, Dept Psychiat, D-48149 Munster, Germany

[6] Univ Melbourne, Melbourne Med Sch, Dept Psychiat, Melbourne, Vic, Australia

[7] Univ Munster, Inst Translat Psychiat, D-48149 Munster, Germany

[8] AMEOS Clin Ctr Hildesheim, D-31135 Hildesheim, Germany

[9] Ctr Syst Neurosci ZSN, D-30559 Hannover, Germany

[10] Med Sch Hannover, Dept Psychiat, D-30625 Hannover, Germany

[11] Univ Tubingen, Tubingen Ctr Mental Hlth, Dept Psychiat & Psychotherapy, D-72076 Tubingen, Germany

[12] Univ Augsburg, Dept Psychiat Psychotherapy & Psychosomat, Fac Med, Bezirkskrankenhaus Augsburg, D-86156 Augsburg, Germany

[13] Ulm Univ, Bezirkskrankenhaus Gunzburg, Dept Psychiat 2, D-89312 Gunzburg, Germany

[14] Ruhr Univ Bochum, LWL Univ Hosp, Dept Psychiat, D-44791 Bochum, Germany

[15] Agaples Diakonieklinikum, Dept Psychiat & Psychotherapy, D-27356 Rotenburg, Germany

[16] Ahvaz Jundishapur Univ Med Sci, Dept Immunol, Fac Med, Ahvaz, Iran

[17] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, D-20246 Hamburg, Germany

[18] Hlth North Hosp Grp, Dept Psychiat, D-28102 Bremen, Germany

[19] Acad Hosp Univ Konstanz, Ctr Psychiat Reichenau, D-78479 Constance, Germany

[20] Univ Med Ctr Rostock, Dept Psychosomat Med & Psychotherapy, D-18147 Rostock, Germany

[21] Psychiatrieverbund Oldenburger Land gGmbH, Karl Jaspers Klin, D-26160 Bad Zwischenahn, Germany

[22] Univ Bonn, Univ Hosp Bonn, Fac Med, Dept Psychiat & Psychotherapy, D-53105 Bonn, Germany

[23] Univ Bonn, Univ Hosp Bonn, Fac Med, Inst Human Genet, D-53127 Bonn, Germany

[24] SUNY Upstate Med Univ, Dept Psychiat & Behavorial Sci, Syracuse, NY 13210 USA

来源：

TRANSLATIONAL PSYCHIATRY | 2023年 / 13卷 / 01期

基金：

欧盟地平线“2020”;

关键词：

ANTIPSYCHOTIC MEDICATION; RATING-SCALE; IMPAIRMENT; THERAPY; METAANALYSES; REMEDIATION; DEFICITS; LITHIUM; MEMORY;

D O I：

10.1038/s41398-023-02373-x

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Existing guidelines recommend psychopharmacological treatment for the management of schizophrenia and bipolar disorder as part of holistic treatment concepts. About half of the patients do not take their medication regularly, although treatment adherence can prevent exacerbations and re-hospitalizations. To date, the relationship between medication adherence and cognitive performance is understudied. Therefore, this study investigated the relationship between medication adherence and cognitive performance by analyzing the data of 862 participants with schizophrenia-spectrum and bipolar disorders (mean [SD] age, 41.9 [12.48] years; 44.8% female) from a multicenter study (PsyCourse Study). Z-scores for three cognitive domains were calculated, global functioning was measured with the Global Assessment of Functioning Scale, and adherence was assessed by a self-rating questionnaire. We evaluated four multiple linear regression models and built three clusters with hierarchical cluster analyses. Higher adherence behavior (p < 0.001) was associated with better global functioning but showed no impact on the cognitive domains learning and memory, executive function, and psychomotor speed. The hierarchical cluster analysis resulted in three clusters with different cognitive performances, but patients in all clusters showed similar adherence behavior. The study identified cognitive subgroups independent of diagnoses, but no differences were found in the adherence behavior of the patients in these new clusters. In summary, medication adherence was associated with global but not cognitive functioning in patients with schizophrenia-spectrum and bipolar disorders. In both diagnostic groups, cognitive function might be influenced by various factors but not medication adherence.

引用

页数：10

共 50 条

[1] Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study
Kirchner, Sophie-Kathrin
Lauseker, Michael
Adorjan, Kristina
Anderson-Schmidt, Heike
Anghelescu, Ion-George
Baune, Bernhardt T.
Budde, Monika
Dannlowski, Udo
Dietrich, Detlef E.
Fallgatter, Andreas J.
Falkai, Peter
Figge, Christian
Gade, Katrin
Heilbronner, Urs
Hiendl, Lena
Juckel, Georg
Kalman, Janos L.
Kloehn-Saghatolislam, Farahnaz
Konrad, Carsten
Lang, Fabian U.
Oraki Kohshour, Mojtaba
Papiol, Sergi
Reich-Erkelenz, Daniela
Reimer, Jens
Reininghaus, Eva Z.
Schaupp, Sabrina K.
Schmauss, Max
Schmitt, Andrea
Schulte, Eva Christina
Senner, Simon
Spitzer, Carsten
Vogl, Thomas
Zimmermann, Joerg
Hasan, Alkomiet
Schulze, Thomas G.
Senner, Fanny
FRONTIERS IN PSYCHIATRY, 2022, 12
[2] A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders
Sendt, Kyra-Verena
Tracy, Derek Kenneth
Bhattacharyya, Sagnik
PSYCHIATRY RESEARCH, 2015, 225 (1-2) : 14 - 30
[3] Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study
Lee, R. S. C.
Hermens, D. F.
Naismith, S. L.
Lagopoulos, J.
Jones, A.
Scott, J.
Chitty, K. M.
White, D.
Robillard, R.
Scott, E. M.
Hickie, I. B.
TRANSLATIONAL PSYCHIATRY, 2015, 5 : e555 - e555
[4] Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum
Van Rheenen, T. E.
Lewandowski, K. E.
Tan, E. J.
Ospina, L. H.
Ongur, D.
Neill, E.
Gurvich, C.
Pantelis, C.
Malhotra, A. K.
Rossell, S. L.
Burdick, K. E.
PSYCHOLOGICAL MEDICINE, 2017, 47 (10) : 1848 - 1864
[5] Relation of medication adherence to cognitive functions in egyptian patients with bipolar I disorder
Khalil, Afaf Hamed
El Shahawi, Heba Hamed
Abdelgawad, Ahmed Saber
Abdeen, Mai SeifElDin
El Serafi, Doha Mustafa
Khalil, Sherien Ahmed
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (04) : 193 - 200
[6] Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: Results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study
Hong, Jihyung
Reed, Catherine
Novick, Diego
Maria Haro, Josep
Aguado, Jaume
PSYCHIATRY RESEARCH, 2011, 190 (01) : 110 - 114
[7] Stigma, discrimination and medication adherence in schizophrenia: Results from the Swedish COAST study
Brain, Cecilia
Sameby, Birgitta
Allerby, Katarina
Quinlan, Patrick
Joas, Erik
Lindstrom, Eva
Burns, Tom
Waern, Margda
PSYCHIATRY RESEARCH, 2014, 220 (03) : 811 - 817
[8] Cognitive functioning of bipolar I patients and relatives from families with or without schizophrenia or schizoaffective disorder
Antila, Mervi
Partonen, Timo
Kieseppa, Tuula
Suvisaari, Jaana
Eerola, Mervi
Lonnqvist, Jouko
Tuulio-Henriksson, Annamari
JOURNAL OF AFFECTIVE DISORDERS, 2009, 116 (1-2) : 70 - 79
[9] Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia
Dalkner, Nina
Moore, Raeanne C.
Depp, Colin A.
Ackerman, Robert A.
Pinkhame, Amy E.
Harvey, Philip D.
SCHIZOPHRENIA RESEARCH, 2023, 252 : 1 - 9
[10] Genome-wide association study of cognitive performance in US veterans with schizophrenia or bipolar disorder
Harvey, Philip D.
Sun, Ning
Bigdeli, Tim B.
Fanous, Ayman H.
Aslan, Mihaela
Malhotra, Anil K.
Lu, Qiongshi
Hu, Yiming
Li, Boyang
Chen, Quan
Mane, Shrikant
Miller, Perry
Rajeevan, Nallakkandi
Sayward, Frederick
Cheung, Kei-Hoi
Li, Yuli
Greenwood, Tiffany A.
Gur, Raquel E.
Braff, David L.
Brophy, Mary
Pyarajan, Saiju
O'Leary, Timothy J.
Gleason, Theresa
Przygodszki, Ronald
Muralidhar, Sumitra
Gaziano, J. Michael
Concato, John
Zhao, Hongyu
Siever, Larry J.
Braff, David L.
Calkins, Monica E.
Freedman, Robert
Green, Michael F.
Greenwood, Tiffany A.
Gur, Raquel E.
Gur, Ruben C.
Lazzeroni, Laura C.
Light, Gregory A.
Nuechterlein, Keith H.
Radant, Allen D.
Seidman, Larry J.
Siever, Larry J.
Silverman, Jeremy M.
Stone, William S.
Sugar, Catherine A.
Swerdlow, Neal R.
Tsuang, Debby W.
Tsuang, Ming T.
Turetsky, Bruce I.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2020, 183 (03) : 181 - 194

← 1 2 3 4 5 →